Novigenix on Bioeconhttps://en.bioecon.ru/companies/novigenix/Recent content in Novigenix on BioeconHugoen-USMon, 20 Jul 2026 16:20:20 +0700Multi-cancer early detection (MCED)https://en.bioecon.ru/technology/multi-cancer-early-detection/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/multi-cancer-early-detection/A single blood draw screening asymptomatic, average-risk individuals for signals of dozens of cancer types simultaneously, aiming to catch cancer before symptoms appear — distinct from treatment-matched companion diagnostics: GRAIL’s Galleri (US), Exact Sciences’ Cancerguard (US) and Freenome (US), Novigenix in Switzerland, and Singlera Genomics in China.